| Item Type | Name |
|
Concept
|
Factor X
|
|
Concept
|
Immunologic Factors
|
|
Concept
|
Fibroblast Growth Factors
|
|
Concept
|
Insulin-Like Growth Factor I
|
|
Concept
|
Platelet-Derived Growth Factor
|
|
Concept
|
Nerve Growth Factors
|
|
Concept
|
Factor XIII
|
|
Concept
|
Plasmids
|
|
Concept
|
von Willebrand Factor
|
|
Concept
|
Endothelial Growth Factors
|
|
Concept
|
Time Factors
|
|
Concept
|
Tumor Necrosis Factor-alpha
|
|
Concept
|
Transforming Growth Factor beta
|
|
Concept
|
Factor XIIIa
|
|
Concept
|
Receptors, Growth Factor
|
|
Concept
|
Basic-Leucine Zipper Transcription Factors
|
|
Concept
|
Brain-Derived Neurotrophic Factor
|
|
Concept
|
Insulin-Like Growth Factor Binding Proteins
|
|
Concept
|
Vascular Endothelial Growth Factor Receptor-2
|
|
Concept
|
Vascular Endothelial Growth Factors
|
|
Concept
|
Hypoxia-Inducible Factor 1, alpha Subunit
|
|
Concept
|
Nerve Growth Factor
|
|
Concept
|
STAT3 Transcription Factor
|
|
Concept
|
Transforming Growth Factor beta1
|
|
Concept
|
Vascular Endothelial Growth Factor Receptor-3
|
|
Concept
|
SOXB1 Transcription Factors
|
|
Concept
|
Transcription Factor RelA
|
|
Concept
|
Fibroblast Growth Factor 1
|
|
Concept
|
Leukemia Inhibitory Factor
|
|
Concept
|
Vascular Endothelial Growth Factor A
|
|
Concept
|
Vascular Endothelial Growth Factor C
|
|
Concept
|
Fibroblast Growth Factor 2
|
|
Concept
|
Vascular Endothelial Growth Factor Receptor-1
|
|
Academic Article
|
Part II: Fibroblasts preferentially migrate in the direction of principal strain.
|
|
Academic Article
|
Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering.
|
|
Academic Article
|
Local thrombin synthesis and fibrin formation in an in vitro thrombosis model result in platelet recruitment and thrombus stabilization on collagen in heparinized blood.
|
|
Academic Article
|
Materials science. Enhancing drug function.
|
|
Academic Article
|
Extracellular Matrix-Inspired Growth Factor Delivery Systems for Skin Wound Healing.
|
|
Academic Article
|
The promotion of endothelial cell attachment and spreading using FNIII10 fused to VEGF-A165.
|
|
Academic Article
|
Treatment of nonunions with nonglycosylated recombinant human bone morphogenetic protein-2 delivered from a fibrin matrix.
|
|
Academic Article
|
Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth.
|
|
Academic Article
|
Pattern stability under cell culture conditions--a comparative study of patterning methods based on PLL-g-PEG background passivation.
|
|
Academic Article
|
Tenascin C promiscuously binds growth factors via its fifth fibronectin type III-like domain.
|
|
Academic Article
|
Neurite extension and in vitro myelination within three-dimensional modified fibrin matrices.
|
|
Academic Article
|
Proteolytic processing regulates placental growth factor activities.
|
|
Academic Article
|
RNA interference targeting hypoxia inducible factor 1alpha reduces post-operative adhesions in rats.
|
|
Academic Article
|
Discovery of a sulfated tetrapeptide that binds to vascular endothelial growth factor.
|
|
Academic Article
|
A feeder-free, defined three-dimensional polyethylene glycol-based extracellular matrix niche for culture of human embryonic stem cells.
|
|
Academic Article
|
IGF-1-containing multi-layered collagen-fibrin hybrid scaffolds for bladder tissue engineering.
|
|
Academic Article
|
Biomolecular hydrogels formed and degraded via site-specific enzymatic reactions.
|
|
Academic Article
|
Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events.
|
|
Academic Article
|
Microfluidic production of bioactive fibrin micro-beads embedded in crosslinked collagen used as an injectable bulking agent for urinary incontinence treatment.
|
|
Academic Article
|
In situ cell manipulation through enzymatic hydrogel photopatterning.
|
|
Academic Article
|
Laminin heparin-binding peptides bind to several growth factors and enhance diabetic wound healing.
|
|
Academic Article
|
VEGFR-3 neutralization inhibits ovarian lymphangiogenesis, follicle maturation, and murine pregnancy.
|
|
Academic Article
|
Activation of cell-survival transcription factor NFkappaB in L1Ig6-stimulated endothelial cells.
|
|
Academic Article
|
Improving Efficacy and Safety of Agonistic Anti-CD40 Antibody Through Extracellular Matrix Affinity.
|
|
Academic Article
|
Efficacy of adhesion barriers. Resorbable hydrogel, oxidized regenerated cellulose and hyaluronic acid.
|
|
Academic Article
|
Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity.
|
|
Academic Article
|
Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix.
|
|
Academic Article
|
Extracellular matrix and growth factor engineering for controlled angiogenesis in regenerative medicine.
|
|
Academic Article
|
Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF164.
|
|
Academic Article
|
Repair of bone defects using synthetic mimetics of collagenous extracellular matrices.
|
|
Academic Article
|
Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix.
|
|
Academic Article
|
In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles.
|
|
Academic Article
|
Fibrin gels engineered with pro-angiogenic growth factors promote engraftment of pancreatic islets in extrahepatic sites in mice.
|
|
Academic Article
|
Long-term maintenance of mouse embryonic stem cell pluripotency by manipulating integrin signaling within 3D scaffolds without active Stat3.
|
|
Academic Article
|
Matrix-bound growth factors in tissue repair.
|
|
Academic Article
|
The role of actively released fibrin-conjugated VEGF for VEGF receptor 2 gene activation and the enhancement of angiogenesis.
|
|
Academic Article
|
Separation of the arterial wall from blood contact using hydrogel barriers reduces intimal thickening after balloon injury in the rat: the roles of medial and luminal factors in arterial healing.
|
|
Academic Article
|
Engineered insulin-like growth factor-1 for improved smooth muscle regeneration.
|
|
Academic Article
|
Enhancement of bone healing using non-glycosylated rhBMP-2 released from a fibrin matrix in dogs and cats.
|
|
Academic Article
|
Engineered fibrin matrices for functional display of cell membrane-bound growth factor-like activities: study of angiogenic signaling by ephrin-B2.
|
|
Academic Article
|
Rapid induction of functional and morphological continuity between severed ends of mammalian or earthworm myelinated axons.
|
|
Academic Article
|
Enhanced endothelial cell retention on shear-stressed synthetic vascular grafts precoated with RGD-cross-linked fibrin.
|
|
Academic Article
|
Matrix-bound sixth Ig-like domain of cell adhesion molecule L1 acts as an angiogenic factor by ligating alphavbeta3-integrin and activating VEGF-R2.
|
|
Academic Article
|
Sorting live stem cells based on Sox2 mRNA expression.
|
|
Academic Article
|
PEG-b-PPS-b-PEI micelles and PEG-b-PPS/PEG-b-PPS-b-PEI mixed micelles as non-viral vectors for plasmid DNA: tumor immunotoxicity in B16F10 melanoma.
|
|
Academic Article
|
MMP-2 sensitive, VEGF-bearing bioactive hydrogels for promotion of vascular healing.
|
|
Academic Article
|
Oxidation-responsive polymeric vesicles.
|
|
Academic Article
|
Biopolymeric delivery matrices for angiogenic growth factors.
|
|
Academic Article
|
Development of fibrin derivatives for controlled release of heparin-binding growth factors.
|
|
Academic Article
|
Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa.
|
|
Academic Article
|
Covalently conjugated VEGF--fibrin matrices for endothelialization.
|
|
Academic Article
|
Enhanced intimal thickening of expanded polytetrafluoroethylene grafts coated with fibrin or fibrin-releasing vascular endothelial growth factor in the pig carotid artery interposition model.
|
|
Academic Article
|
Network formation and degradation behavior of hydrogels formed by Michael-type addition reactions.
|
|
Academic Article
|
Engineering the growth factor microenvironment with fibronectin domains to promote wound and bone tissue healing.
|
|
Academic Article
|
Development of growth factor fusion proteins for cell-triggered drug delivery.
|
|
Academic Article
|
Bone healing in the rat and dog with nonglycosylated BMP-2 demonstrating low solubility in fibrin matrices.
|
|
Academic Article
|
Local induction of lymphangiogenesis with engineered fibrin-binding VEGF-C promotes wound healing by increasing immune cell trafficking and matrix remodeling.
|
|
Academic Article
|
Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices.
|
|
Academic Article
|
Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth.
|
|
Academic Article
|
Interfacial reactivity of block copolymers: understanding the amphiphile-to-hydrophile transition.
|
|
Academic Article
|
Peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1alpha variant for local induction of angiogenesis.
|
|
Academic Article
|
Intraarterial protein delivery via intimally-adherent bilayer hydrogels.
|
|
Academic Article
|
Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing.
|
|
Academic Article
|
The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain.
|
|
Academic Article
|
Extracellular matrix-inspired growth factor delivery systems for bone regeneration.
|
|
Academic Article
|
Sustained release of human growth hormone from in situ forming hydrogels using self-assembly of fluoroalkyl-ended poly(ethylene glycol).
|
|
Academic Article
|
Engineering growth factors for regenerative medicine applications.
|
|
Academic Article
|
Materials engineering for immunomodulation.
|
|
Academic Article
|
Bioluminescent and micro-computed tomography imaging of bone repair induced by fibrin-binding growth factors.
|
|
Academic Article
|
A hydrogel system for stimulus-responsive, oxygen-sensitive in situ gelation.
|
|
Academic Article
|
The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing.
|
|
Academic Article
|
Engineered collagen-binding serum albumin as a drug conjugate carrier for cancer therapy.
|
|
Academic Article
|
Growth factors with enhanced syndecan binding generate tonic signalling and promote tissue healing.
|
|
Academic Article
|
Targeting inflammatory sites through collagen affinity enhances the therapeutic efficacy of anti-inflammatory antibodies.
|
|
Academic Article
|
Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy.
|
|
Academic Article
|
Conferring extracellular matrix affinity enhances local therapeutic efficacy of anti-TNF-a antibody in a murine model of rheumatoid arthritis.
|
|
Academic Article
|
Suppression of Rheumatoid Arthritis by Enhanced Lymph Node Trafficking of Engineered Interleukin-10 in Murine Models.
|
|
Academic Article
|
Persistent antigen exposure via the eryptotic pathway drives terminal T cell dysfunction.
|
|
Academic Article
|
Lymphangiogenesis-inducing vaccines elicit potent and long-lasting T cell immunity against melanomas.
|
|
Academic Article
|
Engineered bridge protein with dual affinity for bone morphogenetic protein-2 and collagen enhances bone regeneration for spinal fusion.
|
|
Academic Article
|
Robust coupling of angiogenesis and osteogenesis by VEGF-decorated matrices for bone regeneration.
|
|
Academic Article
|
Therapeutic arteriogenesis by factor-decorated fibrin matrices promotes wound healing in diabetic mice.
|
|
Concept
|
Placenta Growth Factor
|
|
Grant
|
Engineering Growth Factor-ECM Interactions to Heal Chronic Wounds in Type 1 Diabetes
|
|
Grant
|
INTRAVASCULAR GELS FOR MODULATION OF ARTERIAL HEALING
|